annual CFO:
-$232.32M-$48.15M(-26.14%)Summary
- As of today (September 19, 2025), VRDN annual cash flow from operations is -$232.32 million, with the most recent change of -$48.15 million (-26.14%) on December 31, 2024.
- During the last 3 years, VRDN annual CFO has fallen by -$177.74 million (-325.64%).
- VRDN annual CFO is now -19790.33% below its all-time high of -$1.17 million, reached on December 31, 2013.
Performance
VRDN Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$75.37M+$17.28M(+18.65%)Summary
- As of today (September 19, 2025), VRDN quarterly cash flow from operations is -$75.37 million, with the most recent change of +$17.28 million (+18.65%) on June 30, 2025.
- Over the past year, VRDN quarterly CFO has dropped by -$29.32 million (-63.65%).
- VRDN quarterly CFO is now -35826.12% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$309.06M-$29.32M(-10.48%)Summary
- As of today (September 19, 2025), VRDN TTM cash flow from operations is -$309.06 million, with the most recent change of -$29.32 million (-10.48%) on June 30, 2025.
- Over the past year, VRDN TTM CFO has dropped by -$140.80 million (-83.68%).
- VRDN TTM CFO is now -147213.63% below its all-time high of -$209.80 thousand, reached on December 1, 2012.
Performance
VRDN TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
VRDN Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -26.1% | -63.6% | -83.7% |
| 3 y3 years | -325.6% | -316.8% | -357.6% |
| 5 y5 years | -544.3% | -1010.2% | -856.2% |
VRDN Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -325.6% | at low | -316.8% | +18.6% | -357.6% | at low |
| 5 y | 5-year | -680.1% | at low | -1379.3% | +18.6% | -998.0% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | +18.6% | <-9999.0% | at low |
VRDN Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$75.37M(-18.7%) | -$309.06M(+10.5%) |
| Mar 2025 | - | -$92.65M(+26.3%) | -$279.75M(+20.4%) |
| Dec 2024 | -$232.32M(+26.1%) | -$73.33M(+8.3%) | -$232.32M(+17.9%) |
| Sep 2024 | - | -$67.71M(+47.0%) | -$196.99M(+17.1%) |
| Jun 2024 | - | -$46.06M(+1.8%) | -$168.26M(+0.5%) |
| Mar 2024 | - | -$45.22M(+19.0%) | -$167.42M(-9.1%) |
| Dec 2023 | -$184.17M(+96.3%) | -$38.00M(-2.5%) | -$184.17M(+26.0%) |
| Sep 2023 | - | -$38.98M(-13.8%) | -$146.17M(+36.4%) |
| Jun 2023 | - | -$45.21M(-27.0%) | -$107.19M(+33.9%) |
| Mar 2023 | - | -$61.97M(+242.7%) | -$80.06M(+18.5%) |
| Dec 2022 | -$93.84M(+71.9%) | - | - |
| Jun 2022 | - | -$18.09M(-14.0%) | -$67.54M(+5.4%) |
| Mar 2022 | - | -$21.04M(+27.3%) | -$64.08M(+17.4%) |
| Dec 2021 | -$54.58M(+83.3%) | -$16.54M(+39.2%) | -$54.58M(+15.0%) |
| Sep 2021 | - | -$11.88M(-18.8%) | -$47.48M(+16.7%) |
| Jun 2021 | - | -$14.63M(+26.8%) | -$40.70M(+23.9%) |
| Mar 2021 | - | -$11.54M(+22.3%) | -$32.86M(+10.3%) |
| Dec 2020 | -$29.78M(-17.4%) | -$9.44M(+85.2%) | -$29.78M(+5.8%) |
| Sep 2020 | - | -$5.09M(-25.0%) | -$28.15M(-12.9%) |
| Jun 2020 | - | -$6.79M(-19.7%) | -$32.32M(-1.2%) |
| Mar 2020 | - | -$8.46M(+8.4%) | -$32.71M(-9.3%) |
| Dec 2019 | -$36.06M | -$7.81M(-15.8%) | -$36.06M(-1.0%) |
| Sep 2019 | - | -$9.27M(+29.2%) | -$36.42M(+7.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | -$7.17M(-39.2%) | -$33.96M(+8.5%) |
| Mar 2019 | - | -$11.81M(+44.5%) | -$31.29M(+16.6%) |
| Dec 2018 | -$26.84M(-4.7%) | -$8.18M(+20.2%) | -$26.84M(+3.6%) |
| Sep 2018 | - | -$6.80M(+51.0%) | -$25.91M(+4.6%) |
| Jun 2018 | - | -$4.51M(-38.8%) | -$24.77M(-9.4%) |
| Mar 2018 | - | -$7.36M(+1.6%) | -$27.34M(-2.9%) |
| Dec 2017 | -$28.17M(+289.5%) | -$7.24M(+27.9%) | -$28.17M(+16.3%) |
| Sep 2017 | - | -$5.66M(-20.0%) | -$24.21M(-6.1%) |
| Jun 2017 | - | -$7.08M(-13.5%) | -$25.79M(+24.5%) |
| Mar 2017 | - | -$8.18M(+149.0%) | -$20.72M(+40.4%) |
| Dec 2016 | -$7.23M(+4.8%) | -$3.29M(-54.6%) | -$14.76M(+15.6%) |
| Sep 2016 | - | -$7.24M(+260.5%) | -$12.77M(+63.0%) |
| Jun 2016 | - | -$2.01M(-9.6%) | -$7.83M(-2.2%) |
| Mar 2016 | - | -$2.22M(+71.1%) | -$8.01M(+16.1%) |
| Dec 2015 | -$6.90M(+211.7%) | -$1.30M(-43.6%) | -$6.90M(+4.6%) |
| Sep 2015 | - | -$2.30M(+5.4%) | -$6.60M(+28.8%) |
| Jun 2015 | - | -$2.19M(+97.1%) | -$5.12M(+74.4%) |
| Mar 2015 | - | -$1.11M(+11.3%) | -$2.94M(+60.7%) |
| Dec 2014 | -$2.21M(+89.5%) | -$996.80K(+20.0%) | -$1.83M(+53.8%) |
| Sep 2014 | - | -$831.00K(+132.4%) | -$1.19M(+232.4%) |
| Dec 2013 | -$1.17M(-81.2%) | -$357.50K(+70.4%) | -$357.50K(+70.4%) |
| Dec 2012 | -$6.22M | - | - |
| Dec 2012 | - | -$209.80K | -$209.80K |
FAQ
- What is Viridian Therapeutics, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual CFO year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly CFO year-on-year change?
- What is Viridian Therapeutics, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM CFO year-on-year change?
What is Viridian Therapeutics, Inc. annual cash flow from operations?
The current annual CFO of VRDN is -$232.32M
What is the all time high annual CFO for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual cash flow from operations is -$1.17M
What is Viridian Therapeutics, Inc. annual CFO year-on-year change?
Over the past year, VRDN annual cash flow from operations has changed by -$48.15M (-26.14%)
What is Viridian Therapeutics, Inc. quarterly cash flow from operations?
The current quarterly CFO of VRDN is -$75.37M
What is the all time high quarterly CFO for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly cash flow from operations is -$209.80K
What is Viridian Therapeutics, Inc. quarterly CFO year-on-year change?
Over the past year, VRDN quarterly cash flow from operations has changed by -$29.32M (-63.65%)
What is Viridian Therapeutics, Inc. TTM cash flow from operations?
The current TTM CFO of VRDN is -$309.06M
What is the all time high TTM CFO for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM cash flow from operations is -$209.80K
What is Viridian Therapeutics, Inc. TTM CFO year-on-year change?
Over the past year, VRDN TTM cash flow from operations has changed by -$140.80M (-83.68%)